Second cancers in chronic lymphocytic leukemia: growing importance in the era of improved treatment outcomes

Leuk Lymphoma. 2015 Jun;56(6):1575-6. doi: 10.3109/10428194.2015.1030643. Epub 2015 May 12.

Authors

Petra Langerbeins¹, Christian Maurer, Paula Cramer, Barbara Eichhorst, Michael Hallek

Affiliation

¹ Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne , Cologne , Germany.

PMID: 25804766
DOI: 10.3109/10428194.2015.1030643

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
Leukemia, Myeloid, Acute / chemically induced*
Male
Myelodysplastic Syndromes / chemically induced*
Neoplasms, Second Primary / chemically induced*